Harvard School of Public Health: GLP-1 Drugs Combined With Healthy Lifestyle Habits Linked With Reduced Cardiovascular Risk Among Diabetes Patients
February 25, 2026
February 25, 2026
BOSTON, Massachusetts, Feb. 25 (TNSjou) -- Harvard University T.H. Chan School of Public Health issued the following news release:
* * *
GLP-1 drugs combined with healthy lifestyle habits linked with reduced cardiovascular risk among diabetes patients
By Maya Brownstein
Individuals living with type 2 diabetes (T2D) had a significantly lower risk of poor cardiovascular health when they used a GLP-1 receptor agonist (GLP-1 RA) in combination with . . .
* * *
GLP-1 drugs combined with healthy lifestyle habits linked with reduced cardiovascular risk among diabetes patients
By Maya Brownstein
Individuals living with type 2 diabetes (T2D) had a significantly lower risk of poor cardiovascular health when they used a GLP-1 receptor agonist (GLP-1 RA) in combination with . . .